Progyny, Inc. (PGNY)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,242	1,167	1,089	786.91	500.62	344.86
Revenue Growth (YoY)	9.62%	7.22%	38.34%	57.19%	45.17%	50.14%
Cost of Revenue	964.52	913.86	849.8	619.59	388.49	274.8
Gross Profit	277.44	253.36	238.8	167.33	112.14	70.06
Selling, General & Admin	200.67	185.91	176.62	143.98	79.8	61.71
Operating Expenses	200.67	185.91	176.62	143.98	79.8	61.71
Operating Income	76.77	67.46	62.18	23.34	32.34	8.35
Interest & Investment Income	12.46	15.75	8.51	1.1	0.46	0.12
Other Non Operating Income (Expenses)	-	-	-	-	-	0.21
EBT Excluding Unusual Items	89.23	83.2	70.69	24.44	32.8	8.68
Gain (Loss) on Sale of Investments	-	-	-	-	-0.37	-
Pretax Income	89.23	83.2	70.69	24.44	32.44	8.68
Income Tax Expense	36.11	28.87	8.65	-5.92	-33.33	-37.78
Earnings From Continuing Operations	53.12	54.34	62.04	30.36	65.77	46.46
Net Income	53.12	54.34	62.04	30.36	65.77	46.46
Net Income to Common	53.12	54.34	62.04	30.36	65.77	46.46
Net Income Growth	-15.34%	-12.41%	104.35%	-53.84%	41.56%	-
Shares Outstanding (Basic)	87	91	95	92	89	86
Shares Outstanding (Diluted)	90	95	101	100	100	99
Shares Change (YoY)	-9.71%	-5.19%	0.72%	-0.40%	1.31%	377.72%
EPS (Basic)	0.61	0.59	0.65	0.33	0.74	0.54
EPS (Diluted)	0.58	0.57	0.62	0.30	0.66	0.47
EPS Growth	-7.31%	-8.06%	106.67%	-54.55%	40.43%	-
Free Cash Flow	190.2	173.7	185.17	77.15	23.91	35.17
Free Cash Flow Per Share	2.10	1.82	1.84	0.77	0.24	0.35
Gross Margin	22.34%	21.71%	21.94%	21.26%	22.40%	20.32%
Operating Margin	6.18%	5.78%	5.71%	2.97%	6.46%	2.42%
Profit Margin	4.28%	4.66%	5.70%	3.86%	13.14%	13.47%
Free Cash Flow Margin	15.31%	14.88%	17.01%	9.80%	4.78%	10.20%
EBITDA	80.79	70.63	64.47	24.94	33.64	10.25
EBITDA Margin	6.50%	6.05%	5.92%	3.17%	6.72%	2.97%
D&A For EBITDA	4.02	3.18	2.28	1.6	1.3	1.91
EBIT	76.77	67.46	62.18	23.34	32.34	8.35
EBIT Margin	6.18%	5.78%	5.71%	2.97%	6.46%	2.42%
Effective Tax Rate	40.47%	34.69%	12.24%	-	-	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q